317
Views
5
CrossRef citations to date
0
Altmetric
Research Article

Oxidative DNA Damage-Mediated Genomic Heterogeneity Is Regulated by NKX3.1 in Prostate Cancer

, , , , , , & show all
Pages 113-126 | Received 15 Jan 2018, Accepted 19 Jan 2019, Published online: 05 Mar 2019
 

Abstract

The 8-hydroxy-2′-deoxyguanosine (8-OHdG) damages are base damages induced by reactive oxygen species. We aimed to investigate the role of Androgen Receptor and NKX3.1 in 8-OHdG formation and repair activation by quantitating the DNA damage using Aklides.NUK system.

The data demonstrated that the loss of NKX3.1 resulted in increased oxidative DNA damage and its overexpression contributes to the removal of menadione-induced 8-OHdG damage even under oxidative stress conditions. Moreover, 8-oxoguanine DNA glycosylase-1 (OGG1) expression level positively correlates to NKX3.1 expression. Also in this study, first time a reliable cell-based quantitation method for 8-OHdG damages is reported and used for data collection.

Disclosure statement

Dirk Roggenbuck is one of the shareholders of Generic Assays.GmbH and Medipan.GmbH being diagnostic manufacturers. The remaining authors declare no conflict of interest.

Additional information

Funding

This research is supported by a grant [113S044] from Turkish Scientific and Technology Research Council (TUBITAK) to KSK, and COST program EU-ROS, [BM1203] for mobility and data sharing.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.